Creatine for Health & Longevity - Quick Reference Sheet

Creatine for Health & Longevity

Created on 09/22/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5 – Audit

Creatine is a dietary supplement of a compound the body makes and obtains from meat and fish, taken to build and preserve muscle, strength and brain function. At a few grams daily alongside resistance training it reliably adds modest muscle and strength and improves repeated hard efforts. Without training, most of what it adds is water. Memory gains appear mainly in older adults. Safety at ordinary doses is reassuring. (Full Review)

Protocol

Standard maintenance dose
3–5 g daily
Creatine monohydrate, taken continuously
Competing approach — rapid loading
0.3 g/kg daily for 5–7 days
In four doses, then 3–5 g; saturates muscle in a week, with more gastrointestinal upset
Single versus split dosing
Single daily dose
Adequate at 3–5 g; above 5 g per serving, split into 5 g portions
Time to effect
Strength and lean mass
8–12 weeks
Requires concurrent resistance training
Muscle saturation
About 28 days
At 3–5 g daily, or 5–7 days with loading; water-driven weight gain within 3–7 days
Memory
5 days to 24 weeks
No consistent duration relationship; sleep-deprivation effect within three hours of a single large dose

Benefits

Contraindications
  • Chronic kidney disease at stage 3b or worse (filtration rate below 45 mL/min/1.73 m²), single functioning kidney, or kidney transplant
  • Bipolar disorder type I or II, unless supervised by the treating psychiatrist
  • Pregnancy and lactation
  • Anyone taking a kidney-toxic drug whose dose is titrated against serum creatinine
  • Personal history of severe gastrointestinal intolerance to creatine at any dose
Key Interactions
  • Nephrotoxic (kidney-damaging) prescription drugs (ciclosporin, tacrolimus, aminoglycoside antibiotics such as gentamicin, cisplatin)
  • Over-the-counter non-steroidal anti-inflammatory drugs (ibuprofen, naproxen, high-dose aspirin)
  • Diuretics (furosemide, hydrochlorothiazide)
  • Metformin
  • Caffeine (supplement or high-dose coffee, above roughly 300 mg)
  • Serotonin-targeting antidepressants and lithium
  • Statins (atorvastatin, simvastatin)
  • Supplements with additive effects (beta-alanine, HMB, whey protein, sodium bicarbonate)
  • Resistance training

Risk & Side Effects

  • High: Gastrointestinal distress; increase in body mass from water retention; elevated serum creatinine misread as kidney damage
  • Medium: Switch to mania in bipolar disorder
  • Low: Kidney injury in established kidney disease or with kidney-toxic drugs; hair loss attributed to raised dihydrotestosterone; muscle cramping, dehydration and heat intolerance
  • Speculative: Exposure to contaminants and under-dosed products

Monitoring

Marker Target Why
Serum creatinine 0.6–1.0 mg/dL (women), 0.7–1.1 mg/dL (men) Detects the expected supplement artefact and any real change
Cystatin C 0.60–0.95 mg/L Kidney filtration marker unaffected by creatine or muscle mass
eGFR Above 90 mL/min/1.73 m² Tracks true filtration capacity over years
BUN 10–16 mg/dL Second-line kidney and protein-turnover check
HbA1c Below 5.4% Captures the glucose-disposal benefit reported with training
Fasting glucose 75–86 mg/dL Early signal of the metabolic effect before HbA1c moves
ALT 10–26 U/L Confirms no liver strain, the second most common unfounded concern
Body weight Rise of 0.5–1.5 kg in the first 2 weeks, then stable Distinguishes expected water retention from fat gain
Lean body mass No established target; track change from own baseline The primary outcome creatine is taken for
Grip strength Track change from own baseline; below 27 kg (men) or 16 kg (women) marks clinical weakness Cheap, validated proxy for whole-body strength and function
Blood pressure Below 120/80 mmHg Confirms fluid shift is not raising pressure

Cadence: Body weight weekly for the first month; kidney and liver panel at 3 months, then every 6–12 months; body composition and strength benchmarks at 3 months, then annually; every 3–6 months where kidney function is reduced or medication is kidney-cleared

Qualitative Assessment

  • Repetitions completed at a fixed load, and how quickly recovery occurs between sets
  • Perceived effort during the last set of a session compared with the first
  • Recall of names, lists and short sequences, particularly on poorly slept days
  • Mental clarity and processing speed during cognitively demanding work under fatigue
  • Ease of rising from a chair, climbing stairs, and carrying loads over distance
  • Absence of bloating, abdominal discomfort or loose stools after dosing
  • Mood stability, with any elevation, reduced sleep need or racing thoughts treated as a stop signal